Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Fort Pierce › NPI 1386681468
Hospital

Lawnwood Medical Center INC

Lawnwood Medical Center INC was paid $24.26M by Medicaid between Jan 2018 and Dec 2024, across 254 billing codes. Its largest line is 99283, emergency room visit (moderate) — 28% of everything it billed.

33Billing provider infoLAWNWOOD MEDICAL CENTER INC
FORT PIERCE, FL 34950
33aNPI1386681468assigned 05/31/2006
33bProvider typeRehabilitation Hospital Unit
28Total paid$24.26M
24GClaims1,116,207
24DCodes billed254
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rehabilitation Hospital Unit providers in Florida

Rank by total paid#3 of 11
Median peer was paid$15.92M
This provider vs. median1.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201888,227$1.09M
2019205,279$2.85M
2020158,994$2.08M
2021197,011$4.26M
2022220,924$5.91M
2023154,466$4.82M
2024incomplete91,306$3.24M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 28% 81,001 73,673 $6.70M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 18% 57,440 49,003 $4.27M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.6% 17,373 11,725 $1.60M
99282 Emergency department visit for the evaluation and management, low to moderate severity 5.6% 16,243 15,341 $1.35M
80053 Comprehensive metabolic panel 4.6% 48,277 39,404 $1.11M
70450 Computed tomography, head or brain; without contrast material 3.5% 9,166 7,806 $857K
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility 3.4% 2,991 532 $834K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.3% 6,297 5,592 $802K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.8% 6,809 6,336 $670K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.3% 9,578 1,596 $562K
G0378 Hospital observation service, per hour 2.1% 19,866 8,939 $509K
80048 Basic metabolic panel (calcium, ionized) 1.2% 15,532 11,942 $298K
242 more codes
87070 1.2% 19,065 $295K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.2% 2,476 $290K
87275 <1% 32,049 $179K
96361 Intravenous infusion, hydration; each additional hour <1% 2,492 $174K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,858 $166K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,109 $154K
72125 Computed tomography, cervical spine; without contrast material <1% 3,499 $151K
71045 Radiologic examination, chest; single view <1% 35,384 $135K
80047 <1% 4,097 $105K
A9270 Non-covered item or service <1% 15,978 $104K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,914 $100K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,568 $99K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,611 $98K
81001 <1% 28,910 $86K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 11,609 $81K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 4,585 $81K
81025 <1% 8,625 $74K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 8,664 $73K
85027 <1% 71,382 $70K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 30,163 $69K
97163 <1% 1,640 $64K
87088 <1% 12,853 $62K
71046 Radiologic examination, chest; 2 views <1% 7,799 $52K
84703 <1% 13,548 $50K
72131 <1% 1,368 $45K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 484 $44K
81003 <1% 15,440 $42K
73564 <1% 2,231 $41K
84484 <1% 20,131 $40K
73130 <1% 1,851 $40K
73610 <1% 1,653 $39K
73630 <1% 2,064 $37K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 6,152 $36K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 24,712 $35K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 2,055 $35K
12011 <1% 593 $35K
87040 <1% 12,834 $35K
73030 <1% 1,590 $31K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 360 $31K
85610 <1% 15,008 $30K
85730 <1% 13,983 $30K
41899 Unlisted procedure, dentoalveolar structures <1% 83 $30K
97116 <1% 1,290 $29K
70486 <1% 1,010 $28K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 766 $28K
96375 Therapeutic injection; each additional sequential IV push <1% 11,355 $28K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,245 $28K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,191 $27K
84702 <1% 4,924 $27K
12001 <1% 686 $26K
C1769 Guide wire <1% 1,438 $26K
80076 <1% 6,295 $25K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,962 $25K
J3490 Unclassified drugs <1% 565 $24K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,291 $24K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,843 $23K
74018 <1% 1,719 $23K
76830 Ultrasound, transvaginal <1% 1,316 $22K
87077 <1% 3,671 $22K
Q5105 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units <1% 2,778 $22K
93458 <1% 46 $22K
10060 <1% 340 $21K
J1644 Injection, heparin sodium, per 1000 units <1% 4,459 $21K
83735 <1% 11,898 $20K
70491 <1% 74 $20K
73110 <1% 997 $19K
J7030 Infusion, normal saline solution , 1000 cc <1% 20,832 $19K
87480 <1% 2,289 $19K
83605 <1% 12,166 $18K
93971 <1% 1,438 $18K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,504 $15K
72100 <1% 1,278 $15K
86900 <1% 4,011 $15K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 11,043 $15K
83690 <1% 15,819 $15K
86140 <1% 7,986 $14K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 13,574 $14K
J7050 Infusion, normal saline solution, 250 cc <1% 5,175 $14K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,273 $13K
S0077 Injection, clindamycin phosphate, 300 mg <1% 351 $13K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 20,120 $13K
97167 <1% 1,085 $13K
74022 <1% 1,612 $13K
87807 <1% 10,071 $12K
73090 <1% 566 $12K
71250 <1% 144 $12K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,382 $11K
85652 <1% 2,193 $11K
70496 <1% 166 $10K
87276 <1% 32,042 $10K
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room <1% 16 $10K
S0028 Injection, famotidine, 20 mg <1% 1,011 $10K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 164 $10K
72128 <1% 461 $9K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 10,545 $9K
84112 <1% 269 $9K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,287 $9K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,181 $8K
J2704 Injection, propofol, 10 mg <1% 628 $8K
73080 <1% 264 $8K
J1756 Injection, iron sucrose, 1 mg <1% 517 $7K
76819 Fetal biophysical profile; without non-stress testing <1% 698 $7K
82553 <1% 1,238 $7K
96368 <1% 54 $7K
86738 <1% 4,997 $6K
73590 <1% 603 $6K
82040 <1% 1,411 $6K
76801 <1% 221 $6K
72040 <1% 253 $6K
72170 <1% 1,241 $5K
82550 <1% 3,636 $5K
82247 <1% 1,439 $5K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 12,266 $5K
73502 <1% 469 $5K
84155 <1% 1,412 $5K
84450 <1% 1,404 $5K
84460 <1% 1,400 $5K
84075 <1% 1,398 $5K
86901 <1% 5,065 $5K
86850 <1% 2,005 $5K
S5010 5% dextrose and 0.45% normal saline, 1000 ml <1% 102 $4K
83880 <1% 4,372 $4K
12002 <1% 106 $4K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 277 $4K
74019 <1% 410 $4K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,468 $4K
74174 <1% 39 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,630 $4K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,089 $4K
84100 <1% 1,604 $4K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 387 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 52 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,889 $3K
85379 <1% 2,933 $3K
84443 Thyroid stimulating hormone (TSH) <1% 2,494 $3K
71101 <1% 44 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,353 $2K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 44 $2K
70498 <1% 202 $2K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 259 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 420 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 1,027 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,425 $2K
76775 <1% 56 $2K
84132 <1% 144 $2K
P9016 Red blood cells, leukocytes reduced, each unit <1% 16 $1K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 2,417 $1K
97535 Self-care/home management training, each 15 minutes <1% 607 $1K
80061 Lipid panel <1% 696 $1K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 54 $1K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 35 $1K
82805 <1% 373 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,025 $1K
73140 <1% 27 $1K
76870 <1% 41 $1K
70360 <1% 69 $1K
87510 <1% 2,229 $1K
J1815 Injection, insulin, per 5 units <1% 2,117 $864.32
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,420 $841.36
J0360 Injection, hydralazine hcl, up to 20 mg <1% 481 $820.13
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 447 $708.95
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 145 $704.92
C1760 Closure device, vascular (implantable/insertable) <1% 73 $696.50
99152 <1% 76 $696.50
82435 <1% 16 $662.16
82150 <1% 2,204 $629.17
36600 <1% 290 $621.81
J0690 Injection, cefazolin sodium, 500 mg <1% 841 $590.31
87660 <1% 2,229 $579.54
82248 <1% 3,469 $513.54
96376 <1% 1,078 $487.43
94760 <1% 327 $458.66
84295 <1% 16 $458.15
82947 <1% 16 $458.15
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,896 $455.60
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,183 $445.71
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 1,228 $434.70
J2060 Injection, lorazepam, 2 mg <1% 1,537 $416.96
73060 <1% 14 $390.09
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 560 $360.00
87205 <1% 1,394 $352.66
76937 <1% 63 $351.20
82077 <1% 2,052 $339.87
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 409 $330.80
82731 <1% 33 $317.12
73700 <1% 16 $301.92
80320 <1% 1,295 $284.73
93976 <1% 56 $281.75
90714 <1% 679 $241.06
J2550 Injection, promethazine hcl, up to 50 mg <1% 52 $233.77
J3486 Injection, ziprasidone mesylate, 10 mg <1% 254 $196.98
J1650 Injection, enoxaparin sodium, 10 mg <1% 623 $182.26
73120 <1% 20 $180.32
93970 <1% 26 $178.14
76857 <1% 358 $160.91
J3475 Injection, magnesium sulfate, per 500 mg <1% 349 $153.34
84439 <1% 129 $151.02
J1953 Injection, levetiracetam, 10 mg <1% 61 $141.66
J3370 Injection, vancomycin hcl, 500 mg <1% 75 $113.33
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 463 $88.93
87186 <1% 793 $84.85
82270 <1% 29 $76.79
80329 <1% 347 $67.68
82009 <1% 286 $39.61
80069 <1% 20 $27.40
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 178 $13.98
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,835 $9.00
J0456 Injection, azithromycin, 500 mg <1% 860 $8.38
82570 <1% 42 $5.32
86923 <1% 17 $4.29
87340 <1% 240 $3.05
80143 <1% 245 $1.54
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 58 $0.00
85045 0% 258 $0.00
29125 0% 48 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 224 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 70 $0.00
84550 0% 92 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 20 $0.00
J7510 Prednisolone oral, per 5 mg 0% 96 $0.00
83655 0% 19 $0.00
00170 Anesthesia for intraoral procedures, including biopsy 0% 71 $0.00
84156 0% 29 $0.00
85014 0% 49 $0.00
J0692 Injection, cefepime hydrochloride, 500 mg 0% 15 $0.00
82140 0% 34 $0.00
83615 0% 84 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 87 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 147 $0.00
85018 0% 97 $0.00
82746 0% 14 $0.00
J0500 Injection, dicyclomine hcl, up to 20 mg 0% 55 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 67 $0.00
86593 0% 17 $0.00
86317 0% 111 $0.00
86308 0% 40 $0.00
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml 0% 12 $0.00
82607 0% 29 $0.00
87086 Culture, bacterial; quantitative colony count, urine 0% 28 $0.00
82330 0% 29 $0.00
86920 0% 41 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCROSS, RENEE (CFO)
Parent organizationLAWNWOOD MEDICAL CENTER INC
Same official

Other billing entities under CROSS, RENEE

Full network →
ProviderLocationPaid
Charleston Hospital INC.Charleston, WV$3.48M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.